Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 130 articles:
HTML format



Single Articles


    November 2021
  1. MORTIMER TD, Pathela P, Crawley A, Rakeman JL, et al
    The Distribution and Spread of Susceptible and Resistant Neisseria gonorrhoeae Across Demographic Groups in a Major Metropolitan Center.
    Clin Infect Dis. 2021;73:e3146-e3155.
    PubMed     Abstract available


    October 2021
  2. ARGIMON S, Nagaraj G, Shamanna V, Darmavaram S, et al
    Circulation of third-generation cephalosporin resistant Salmonella Typhi in Mumbai, India.
    Clin Infect Dis. 2021 Oct 9. pii: 6385881. doi: 10.1093.
    PubMed     Abstract available


  3. FOWLER VG, Jezek A, Spivak ES, Talkington K, et al
    Urgent, Comprehensive Federal Action Needed To Stem Mortality and Medicare Costs Associated With Antimicrobial Resistance.
    Clin Infect Dis. 2021 Oct 7. pii: 6374435. doi: 10.1093.
    PubMed     Abstract available


  4. ARZIKA AM, Maliki R, Abdou A, Mankara AK, et al
    Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial.
    Clin Infect Dis. 2021;73:1292-1295.
    PubMed     Abstract available


  5. HACKETT S, Teasdale CA, Pals S, Muttiti A, et al
    Drug Resistance Mutations Among South African Children Living With HIV on WHO-recommended ART Regimens.
    Clin Infect Dis. 2021;73:e2217-e2225.
    PubMed     Abstract available


    September 2021
  6. KHATRI AM, Anderson AD, Camargo JF
    Addition Of Oral Fosfomycin To Antimicrobial Salvage Therapy For Persistent Vancomycin-Resistant Enterococcal Bacteremia.
    Clin Infect Dis. 2021 Sep 18. pii: 6372244. doi: 10.1093.
    PubMed    


  7. AVEDISSIAN SN, Scheetz MH, Cortes-Penfield N
    Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than Answers.
    Clin Infect Dis. 2021;73:1128-1129.
    PubMed    


  8. DIONNE B, Lee TC
    Probable Immortal Time Bias in Comparison of Daptomycin and Vancomycin for Methicillin-resistant Staphylococcus Aureus Bloodstream Infections.
    Clin Infect Dis. 2021;73:1127-1128.
    PubMed    


  9. HOLDERMAN JL, Thomas JC, Schlanger K, Black JM, et al
    Sustained Transmission of Neisseria gonorrhoeae with High-Level Resistance to Azithromycin, in Indianapolis, Indiana, 2017-2018.
    Clin Infect Dis. 2021;73:808-815.
    PubMed     Abstract available


    August 2021
  10. CURREN EJ, Lutgring JD, Kabbani S, Diekema DJ, et al
    Advancing Diagnostic Stewardship for Healthcare Associated Infections, Antibiotic Resistance, and Sepsis.
    Clin Infect Dis. 2021 Aug 4. pii: 6338696. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  11. KLAUSNER JD, Bristow CC, Soge OO, Shahkolahi A, et al
    Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.
    Clin Infect Dis. 2021;73:298-303.
    PubMed     Abstract available


  12. ANDRIANAIVOARIMANANA V, Wagner DM, Birdsell DN, Nikolay B, et al
    Transmission of antimicrobial resistant Yersinia pestis during a pneumonic plague outbreak.
    Clin Infect Dis. 2021 Jul 9. pii: 6318455. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  13. KAYE KS, Gupta V, Mulgirigama A, Joshi AV, et al
    Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011-2019: Rising ESBL Strains and Impact on Patient Management.
    Clin Infect Dis. 2021 Jun 18. pii: 6304915. doi: 10.1093.
    PubMed     Abstract available


  14. STEWART AG, Satlin MJ, Schlebusch S, Isler B, et al
    Completing the Picture-Capturing the Resistome in Antibiotic Clinical Trials.
    Clin Infect Dis. 2021;72:e1122-e1129.
    PubMed     Abstract available


  15. AL-HASAN MN
    Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target.
    Clin Infect Dis. 2021;72:2121-2123.
    PubMed    


  16. KARLOWSKY JA, Lob SH, Raddatz J, DePestel DD, et al
    In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United S
    Clin Infect Dis. 2021;72:2112-2120.
    PubMed     Abstract available


  17. KLEIN S, Boutin S, Kocer K, Fiedler MO, et al
    Rapid development of cefiderocol resistance in carbapenem-resistant Enterobacter cloacae during therapy is associated with heterogeneous mutations in the catecholate siderophore receptor cira.
    Clin Infect Dis. 2021 Jun 3. pii: 6291426. doi: 10.1093.
    PubMed     Abstract available


  18. AZARIAN T
    The Importance of Pathogen Whole-Genome Sequencing in Evaluating Interventions to Reduce the Spread of Multidrug-Resistant Organisms in the Healthcare Setting.
    Clin Infect Dis. 2021;72:1888-1890.
    PubMed    


  19. YAHAV D, Tau N, Shepshelovich D
    Assessment of Data Supporting the Efficacy of New Antibiotics for Treating Infections Caused by Multidrug-resistant Bacteria.
    Clin Infect Dis. 2021;72:1968-1974.
    PubMed     Abstract available


    May 2021
  20. WRIGHT WF, Jorgensen SCJ, Spellberg B
    Heaping the Pelion of Vancomycin on the Ossa of Methicillin-resistant Staphylococcus aureus: Back to Basics in Clinical Care and Guidelines.
    Clin Infect Dis. 2021;72:e682-e684.
    PubMed    


  21. HOUPT ER, Ferdous T, Ara R, Ibrahim M, et al
    Clinical Outcomes of Drug-resistant Shigellosis Treated With Azithromycin in Bangladesh.
    Clin Infect Dis. 2021;72:1793-1798.
    PubMed     Abstract available


  22. ROYER G, Clermont O, Condamine B, Mercier-Darty M, et al
    O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance.
    Clin Infect Dis. 2021 May 17. pii: 6277090. doi: 10.1093.
    PubMed    


  23. ROSE W, Fantl M, Geriak M, Nizet V, et al
    Current Paradigms of Combination therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination and For Which Patients?
    Clin Infect Dis. 2021 May 16. pii: 6276527. doi: 10.1093.
    PubMed     Abstract available


  24. WILSON GM, Suda KJ, Fitzpatrick MA, Bartle B, et al
    Risk Factors Associated with Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Positive Cultures in a Cohort of U.S. Veterans.
    Clin Infect Dis. 2021 May 11. pii: 6273455. doi: 10.1093.
    PubMed     Abstract available


  25. SATLIN MJ, Chen L, Douglass C, Hovan M, et al
    Colonization with Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
    Clin Infect Dis. 2021 May 6. pii: 6270940. doi: 10.1093.
    PubMed     Abstract available


  26. KARCHMER AW
    Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia: Beauty Remains in the Eye of the Beholder.
    Clin Infect Dis. 2021;72:1526-1528.
    PubMed    


    April 2021
  27. POTTS CC, Retchless AC, McNamara LA, Marasini D, et al
    Acquisition of ciprofloxacin resistance among an expanding clade of beta-lactamase positive, serogroup Y Neisseria meningitidis in the United States.
    Clin Infect Dis. 2021 Apr 26. pii: 6253703. doi: 10.1093.
    PubMed     Abstract available


  28. GHANI R, Mullish BH, McDonald JAK, Ghazy A, et al
    Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms.
    Clin Infect Dis. 2021;72:1444-1447.
    PubMed     Abstract available


  29. KHANNA S
    Microbiome-based Therapies for Multidrug-resistant Pathobionts: Getting a Step Closer!
    Clin Infect Dis. 2021;72:1448-1449.
    PubMed    


  30. TAMMA PD, Aitken SL, Bonomo RA, Mathers AJ, et al
    Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum beta-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P
    Clin Infect Dis. 2021;72:1109-1116.
    PubMed     Abstract available


    March 2021
  31. FRISBIE L, Weissman SJ, Kapoor H, D'Angeli M, et al
    Antimicrobial Resistance Patterns of Urinary Escherichia coli Among Outpatients in Washington State, 2013-2017: Associations with Age and Sex.
    Clin Infect Dis. 2021 Mar 26. pii: 6188726. doi: 10.1093.
    PubMed     Abstract available


  32. JORGENSEN SCJ, Spellberg B, Shorr AF, Wright WF, et al
    Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant Staphylococcus aureus Infections?-No.
    Clin Infect Dis. 2021 Mar 19. pii: 6178883. doi: 10.1093/cid/ciaa1743.
    PubMed     Abstract available


  33. LODISE TP, Drusano G
    Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First.
    Clin Infect Dis. 2021 Mar 19. pii: 6178884. doi: 10.1093/cid/ciaa1744.
    PubMed     Abstract available


  34. CAREY ME, Jain R, Yousuf M, Maes M, et al
    Spontaneous Emergence of Azithromycin Resistance in Independent Lineages of Salmonella Typhi in Northern India.
    Clin Infect Dis. 2021;72:e120-e127.
    PubMed     Abstract available


    February 2021
  35. STRICH JR, Ricotta E, Warner S, Lai YL, et al
    Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals.
    Clin Infect Dis. 2021;72:611-621.
    PubMed     Abstract available


  36. CHAMBERS HF, Evans SR, Patel R, Cross HR, et al
    Antibacterial Resistance Leadership Group 2.0 - Back to Business.
    Clin Infect Dis. 2021 Feb 15. pii: 6137279. doi: 10.1093.
    PubMed     Abstract available


  37. MULINGANYA GM, Claeys M, Balolebwami SZ, Bamuleke BA, et al
    Etiology of early-onset neonatal sepsis and antibiotic resistance in Bukavu, Democratic Republic of the Congo.
    Clin Infect Dis. 2021 Feb 12. pii: 6133716. doi: 10.1093.
    PubMed     Abstract available


  38. GIANNELLA M, Freire M, Rinaldi M, Abdala E, et al
    Development of a Risk Prediction Model for Carbapenem-Resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study.
    Clin Infect Dis. 2021 Feb 10. pii: 6132093. doi: 10.1093.
    PubMed     Abstract available


  39. HARRIS PNA, Alexander M W
    Beyond the Core Genome: Tracking Plasmids in Outbreaks of Multidrug-resistant Bacteria.
    Clin Infect Dis. 2021;72:421-422.
    PubMed    


  40. DE MAN TJB, Yaffee AQ, Zhu W, Batra D, et al
    Multispecies Outbreak of Verona Integron-Encoded Metallo-ss-Lactamase-Producing Multidrug Resistant Bacteria Driven by a Promiscuous Incompatibility Group A/C2 Plasmid.
    Clin Infect Dis. 2021;72:414-420.
    PubMed     Abstract available


    January 2021
  41. KHADER K, Thomas A, Huskins WC, Stevens V, et al
    Effectiveness of Contact Precautions to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Intensive Care Units.
    Clin Infect Dis. 2021;72.
    PubMed     Abstract available


  42. NELSON RE, Goto M, Samore MH, Jones M, et al
    Expanding an Economic Evaluation of the Veterans Affairs (VA) Methicillin-resistant Staphylococcus aureus (MRSA) Prevention Initiative to Include Prevention of Infections From Other Pathogens.
    Clin Infect Dis. 2021;72.
    PubMed     Abstract available


  43. NELSON RE, Lautenbach E, Chang N, Jones M, et al
    Attributable Cost of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infection in a Long-term Care Center.
    Clin Infect Dis. 2021;72.
    PubMed     Abstract available


  44. SCHWEIZER ML, Richardson K, Vaughan Sarrazin MS, Goto M, et al
    Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections.
    Clin Infect Dis. 2021;72.
    PubMed     Abstract available


  45. RUBIN MA, Nelson RE, Samore MH
    Matching Methods to Problems: Using Data Science and Transmission Modeling to Combat Antimicrobial Resistance.
    Clin Infect Dis. 2021;72.
    PubMed     Abstract available


  46. TANNER WD, Leecaster MK, Zhang Y, Stratford KM, et al
    Environmental Contamination of Contact Precaution and Non-Contact Precaution Patient Rooms in Six Acute Care Facilities.
    Clin Infect Dis. 2021;72.
    PubMed     Abstract available


  47. NELSON RE, Hatfield KM, Wolford H, Samore MH, et al
    National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States.
    Clin Infect Dis. 2021;72.
    PubMed     Abstract available


  48. ADAMSON PC, Klausner JD
    The staying power of pharyngeal gonorrhea: implications for public health and antimicrobial resistance.
    Clin Infect Dis. 2021 Jan 28. pii: 6122636. doi: 10.1093.
    PubMed    


  49. VEKEMANS J, Hasso-Agopsowicz M, Kang G, Hausdorff WP, et al
    Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: a WHO Action Framework.
    Clin Infect Dis. 2021 Jan 25. pii: 6119610. doi: 10.1093.
    PubMed     Abstract available


  50. EL HADDAD L, Hanson BM, Arias CA, Ghantoji SS, et al
    Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms.
    Clin Infect Dis. 2021 Jan 9. pii: 6075650. doi: 10.1093.
    PubMed     Abstract available


  51. BEGIER E, Rosenthal NA, Gurtman A, Kartashov A, et al
    Epidemiology of Invasive Escherichia coli Infection and Antibiotic Resistance Status among Patients Treated in U.S. Hospitals: 2009-2016.
    Clin Infect Dis. 2021 Jan 9. pii: 6074155. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  52. YANG Q, Zhang H, Yu Y, Kong H, et al
    In Vitro Activity of Imipenem/Relebactam Against Enterobacteriaceae Isolates Obtained from Intra-abdominal, Respiratory Tract, and Urinary Tract Infections in China: Study for Monitoring Antimicrobial Resistance Trends (SMART), 2015-2018.
    Clin Infect Dis. 2020;71.
    PubMed     Abstract available


  53. ZONG Z, Wu A, Hu B
    Infection Control in the Era of Antimicrobial Resistance in China: Progress, Challenges, and Opportunities.
    Clin Infect Dis. 2020;71.
    PubMed     Abstract available


  54. QIAO F, Wei L, Feng Y, Ran S, et al
    Handwashing Sink Contamination and Carbapenem-resistant Klebsiella Infection in the Intensive Care Unit: A Prospective Multicenter Study.
    Clin Infect Dis. 2020;71.
    PubMed     Abstract available


  55. ZHAO Y, Lin Q, Liu L, Ma R, et al
    Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
    Clin Infect Dis. 2020;71.
    PubMed     Abstract available


  56. BERCOT B, Charreau I, Clotilde R, Delaugerre C, et al
    High Prevalence and High Rate of Antibiotic Resistance of Mycoplasma genitalium Infections in Men who Have Sex with Men. A Sub-Study of the ANRS Ipergay PrEP Trial.
    Clin Infect Dis. 2020 Dec 11. pii: 6030928. doi: 10.1093/cid/ciaa1832.
    PubMed     Abstract available


  57. KENDALL EA, Kitonsa PJ, Nalutaaya A, Kamoga CE, et al
    The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities.
    Clin Infect Dis. 2020 Dec 6. pii: 6024999. doi: 10.1093/cid/ciaa1824.
    PubMed     Abstract available


  58. QAMAR FN, Yousafzai MT, Dehraj IF, Shakoor S, et al
    Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019.
    Clin Infect Dis. 2020;71.
    PubMed     Abstract available


    November 2020
  59. WILSON BM, Jiang Y, Jump RLP, Colindres RV, et al
    Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.
    Clin Infect Dis. 2020 Nov 27. pii: 6007573. doi: 10.1093/cid/ciaa1769.
    PubMed     Abstract available


  60. TREVAS D, Caliendo AM, Hanson K, Levy J, et al
    Diagnostic Tests Can Stem the Threat of Antimicrobial Resistance: Infectious Disease Professionals Can Help.
    Clin Infect Dis. 2020 Nov 18. pii: 5989648. doi: 10.1093/cid/ciaa1527.
    PubMed     Abstract available


  61. IMLAY HN, Kaul DR
    Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.
    Clin Infect Dis. 2020 Nov 17. pii: 5983750. doi: 10.1093/cid/ciaa1713.
    PubMed     Abstract available


  62. HORN DL, Roberts EA, Shen J, Chan JD, et al
    Outcomes of beta-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.
    Clin Infect Dis. 2020 Nov 5. pii: 5956896. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  63. TAMMA PD, Aitken SL, Bonomo RA, Mathers AJ, et al
    Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections.
    Clin Infect Dis. 2020 Oct 27. pii: 5940736. doi: 10.1093/cid/ciaa1478.
    PubMed     Abstract available


  64. PYNGOTTU A, Scherrer AU, Kouyos R, Huber M, et al
    Predictors of virological failure and time to viral suppression of first line integrase inhibitor based antiretroviral treatment.
    Clin Infect Dis. 2020 Oct 24. pii: 5937176. doi: 10.1093/cid/ciaa1614.
    PubMed     Abstract available


  65. LEWIN-EPSTEIN O, Baruch S, Hadany L, Stein GY, et al
    Predicting antibiotic resistance in hospitalized patients by applying machine learning to electronic medical records.
    Clin Infect Dis. 2020 Oct 18. pii: 5929660. doi: 10.1093/cid/ciaa1576.
    PubMed     Abstract available


  66. PACIOS-MARTINEZ E, Garcia-Monzon C
    Daptomycin plus fosfomycin versus daptomycin alone for methicillin-resistant staphylococcus aureus severe infection: Post hoc analysis is warranted.
    Clin Infect Dis. 2020 Oct 1. pii: 5917171. doi: 10.1093/cid/ciaa1497.
    PubMed    


    September 2020
  67. BABIKER A, Clarke LG, Saul M, Gealey JA, et al
    Changing epidemiology and decreased mortality associated with Carbapenem-resistant Gram-negative bacteria from 2000 - 2017.
    Clin Infect Dis. 2020 Sep 29. pii: 5912806. doi: 10.1093/cid/ciaa1464.
    PubMed     Abstract available


  68. FALCONE M, Tiseo G, Nicastro M, Leonildi A, et al
    Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-Negative infections in ICU patients.
    Clin Infect Dis. 2020 Sep 17. pii: 5907899. doi: 10.1093/cid/ciaa1410.
    PubMed     Abstract available


    August 2020
  69. CROWELL TA, Danboise B, Parikh A, Esber A, et al
    Pre-Treatment and Acquired Antiretroviral Drug Resistance among Persons Living with HIV in Four African Countries.
    Clin Infect Dis. 2020 Aug 12. pii: 5891786. doi: 10.1093/cid/ciaa1161.
    PubMed     Abstract available


  70. FORDE BM, Henderson A, Playford EG, Looke D, et al
    Fatal respiratory diphtheria caused by beta-lactam-resistant Corynebacterium diphtheriae.
    Clin Infect Dis. 2020 Aug 9. pii: 5890099. doi: 10.1093/cid/ciaa1147.
    PubMed     Abstract available


  71. MARKS M, Harding-Esch E
    Antimicrobial Resistance in Gonorrhea: Diagnostics to the Rescue.
    Clin Infect Dis. 2020 Aug 7. pii: 5882187. doi: 10.1093.
    PubMed    


  72. CLANCY CJ, Nguyen MH
    Antibacterial drug development trends in the United States from 1980 through 2019: Agents active against carbapenem-resistant Gram-negative bacteria as case study.
    Clin Infect Dis. 2020 Aug 5. pii: 5881438. doi: 10.1093/cid/ciaa1107.
    PubMed    


    July 2020
  73. PUJOL M, Miro JM, Shaw E, Aguado JM, et al
    Daptomycin plus Fosfomycin versus Daptomycin Alone for Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis. A Randomized Clinical Trial.
    Clin Infect Dis. 2020 Jul 29. pii: 5877897. doi: 10.1093/cid/ciaa1081.
    PubMed     Abstract available


  74. SAHA S, Sajib MSI, Garrett D, Qamar FN, et al
    Antimicrobial Resistance in Typhoidal Salmonella: Around the World in 3 Days.
    Clin Infect Dis. 2020;71.
    PubMed     Abstract available


  75. ALOSAIMY S, Murray KP, Zasowski EJ, Morrisette T, et al
    Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections.
    Clin Infect Dis. 2020 Jul 27. pii: 5876762. doi: 10.1093/cid/ciaa1039.
    PubMed     Abstract available


  76. TARTOF SY, Chen LH, Tian Y, Wei R, et al
    Do Inpatient Antimicrobial Stewardship Programs help us in the Battle against Antimicrobial Resistance?
    Clin Infect Dis. 2020 Jul 15. pii: 5871999. doi: 10.1093/cid/ciaa1004.
    PubMed     Abstract available


  77. RYBAK MJ, Le J, Lodise TP, Levine DP, et al
    Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Ped
    Clin Infect Dis. 2020 Jul 13. pii: 5870833. doi: 10.1093.
    PubMed     Abstract available


  78. STEWART AG, Harris PNA, Chatfield M, Evans SR, et al
    Modern Clinician-initiated Clinical Trials to Determine Optimal Therapy for Multidrug-resistant Gram-negative Infections.
    Clin Infect Dis. 2020;71:433-439.
    PubMed     Abstract available


  79. DIPIPPO AJ, Kontoyiannis DP
    Azole-Associated Pseudohyperaldosteronism: A Class Effect or Azole-Specific?
    Clin Infect Dis. 2020;71:467-468.
    PubMed    


  80. DEELEN JWT, Rottier WC, Giron Ortega JA, Rodriguez-Bano J, et al
    An international prospective cohort study to validate two prediction rules for infections caused by 3rd-generation cephalosporin-resistant Enterobacterales.
    Clin Infect Dis. 2020 Jul 8. pii: 5868963. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  81. SFEIR MM
    Imipenem/Relebactam for Treatment of Carbapenem-Resistant Gram-negative Bacteria: Where Do We Stand on in vitro Susceptibility Testing?
    Clin Infect Dis. 2020 Jun 28. pii: 5868454. doi: 10.1093.
    PubMed    


  82. CHOI SH, Dagher M, Ruffin F, Park LP, et al
    Risk Factors for Recurrent Staphylococcus aureus Bacteremia.
    Clin Infect Dis. 2020 Jun 21. pii: 5860449. doi: 10.1093.
    PubMed     Abstract available


  83. NIEUWLAAT R, Mbuagbaw L, Mertz D, Burrows L, et al
    COVID-19 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
    Clin Infect Dis. 2020 Jun 16. pii: 5858203. doi: 10.1093.
    PubMed     Abstract available


  84. HOGAN PG, Parrish KL, Mork RL, Boyle MG, et al
    HOME2: Household vs. Personalized Decolonization in Households of Children with Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infection - A Randomized Clinical Trial.
    Clin Infect Dis. 2020 Jun 10. pii: 5855689. doi: 10.1093.
    PubMed     Abstract available


  85. WANG J, Cassone M, Gibson K, Lansing B, et al
    Gut microbiota features on nursing home admission are associated with subsequent acquisition of antibiotic resistant organism colonization.
    Clin Infect Dis. 2020 Jun 1. pii: 5849515. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  86. JOHNSON J, Robinson ML, Rajput UC, Valvi C, et al
    High Burden of Bloodstream Infections Associated with Antimicrobial Resistance and Mortality in the Neonatal Intensive Care Unit in Pune, India.
    Clin Infect Dis. 2020 May 18. pii: 5839743. doi: 10.1093.
    PubMed     Abstract available


  87. SULTAN AS, Vila T, Montelongo-Jauregui D, Jabra-Rizk MA, et al
    The Global Emergence of the Fungal Pathogen Candida auris.
    Clin Infect Dis. 2020 May 18. pii: 5838782. doi: 10.1093.
    PubMed    


  88. DOOKIE N, Padayatchi N, Lessells RJ, Naicker CL, et al
    Individualised treatment of Multi-Drug Resistant Tuberculosis using Whole Genome Sequencing and Expanded Drug Susceptibility Testing.
    Clin Infect Dis. 2020 May 8. pii: 5834727. doi: 10.1093.
    PubMed     Abstract available


  89. MACESIC N, Nelson B, Mcconville TH, Giddins MJ, et al
    Emergence of Polymyxin Resistance in Clinical Klebsiella pneumoniae Through Diverse Genetic Adaptations: A Genomic, Retrospective Cohort Study.
    Clin Infect Dis. 2020;70:2084-2091.
    PubMed     Abstract available


  90. ROSA PS, D'Espindula HRS, Melo ACL, Fontes ANB, et al
    Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon.
    Clin Infect Dis. 2020;70:2054-2061.
    PubMed     Abstract available


  91. RAWSON TM, Moore LSP, Zhu N, Ranganathan N, et al
    Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing.
    Clin Infect Dis. 2020 May 2. pii: 5828058. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  92. MARURI F, Guo Y, Blackman A, van der Heijden YF, et al
    Resistance-conferring mutations on whole-genome sequencing of fluoroquinolone-resistant and -susceptible M. tuberculosis isolates: a proposed threshold for identifying resistance.
    Clin Infect Dis. 2020 Apr 29. pii: 5827013. doi: 10.1093.
    PubMed     Abstract available


  93. SOLOMKIN JS
    Is Personalized Colorectal Prophylaxis Ready for Prime Time?
    Clin Infect Dis. 2020;70:1898-1899.
    PubMed    


  94. WANG J, Foxman B, Pirani A, Lapp Z, et al
    Application of combined genomic and transfer analyses to identify factors mediating regional spread of antibiotic resistant bacterial lineages.
    Clin Infect Dis. 2020 Apr 2. pii: 5814952. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  95. HOOK EW, Newman L, Drusano G, Evans S, et al
    Development of New Antimicrobials for Urogenital Gonorrhea Therapy: Clinical Trial Design Considerations.
    Clin Infect Dis. 2020;70:1495-1500.
    PubMed     Abstract available


  96. GORWOOD J, Bourgeois C, Pourcher V, Pourcher G, et al
    The integrase inhibitors dolutegravir and raltegravir exert pro-adipogenic and profibrotic effects and induce insulin resistance in human/simian adipose tissue and human adipocytes.
    Clin Infect Dis. 2020 Mar 13. pii: 5804258. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  97. MCGEE L, Chochua S, Li Z, Mathis S, et al
    Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015-2017.
    Clin Infect Dis. 2020 Feb 15. pii: 5736375. doi: 10.1093.
    PubMed     Abstract available


  98. LI Y, Su X, Le W, Li S, et al
    Mycoplasma genitalium in Symptomatic Male Urethritis: Macrolide Use Is Associated With Increased Resistance.
    Clin Infect Dis. 2020;70:805-810.
    PubMed     Abstract available


  99. KERSH EN, Allen V, Ransom E, Schmerer M, et al
    Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for Azithromycin.
    Clin Infect Dis. 2020;70:798-804.
    PubMed     Abstract available


  100. POPPING S, Verwijs R, Cuypers L, Claassen M, et al
    Transmission of NS5A resistance associated substitutions among men-who-have-sex-with-men recently infected with hepatitis C virus genotype 1a.
    Clin Infect Dis. 2020 Feb 14. pii: 5735665. doi: 10.1093.
    PubMed     Abstract available


  101. SARAVOLATZ LD, Stein GE
    Plazomicin: A New Aminoglycoside.
    Clin Infect Dis. 2020;70:704-709.
    PubMed     Abstract available


    January 2020
  102. PAUL P, Slayton RB, Kallen AJ, Walters MS, et al
    Modeling Regional Transmission and Containment of a Healthcare-associated Multidrug-resistant Organism.
    Clin Infect Dis. 2020;70:388-394.
    PubMed     Abstract available


    November 2019
  103. WALLIS CL, Hughes MD, Ritz J, Viana R, et al
    Diverse HIV-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line ART in Resource Limited Settings.
    Clin Infect Dis. 2019 Nov 14. pii: 5625392. doi: 10.1093/cid/ciz1116.
    PubMed     Abstract available


    October 2019
  104. VANNICE K, Ricaldi J, Nanduri S, Fang FC, et al
    Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to beta-lactam antibiotics.
    Clin Infect Dis. 2019 Oct 20. pii: 5601183. doi: 10.1093/cid/ciz1000.
    PubMed     Abstract available


    September 2019
  105. SHAH M, Paradis S, Betz J, Beylis N, et al
    Multicenter Study of the Accuracy of the BD MAX MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid.
    Clin Infect Dis. 2019 Sep 27. pii: 5574845. doi: 10.1093.
    PubMed     Abstract available


  106. POGUE JM, Kaye KS, Veve MP, Patel TS, et al
    Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas Aeruginosa.
    Clin Infect Dis. 2019 Sep 23. pii: 5572677. doi: 10.1093.
    PubMed     Abstract available


  107. BOULA A, Senghore M, Ngoh R, Tassadjo F, et al
    Hospital-based Surveillance Provides Insights Into the Etiology of Pediatric Bacterial Meningitis in Yaounde, Cameroon, in the Post-Vaccine Era.
    Clin Infect Dis. 2019;69.
    PubMed     Abstract available


    August 2019
  108. POPOVICH KJ, Snitkin ES, Zawitz C, Aroutcheva A, et al
    Frequent MRSA Introductions into an Inner-City Jail: Indications of Community Transmission Networks.
    Clin Infect Dis. 2019 Aug 20. pii: 5551540. doi: 10.1093.
    PubMed     Abstract available


    July 2019
  109. WINCHESTER NE, Maldarelli F, Mejia Y, Dee N, et al
    8-Day Inpatient Directly Observed Therapy for ART Failure: A Tool For Preventing Unnecessary ART Changes and Optimizing Adherence Support.
    Clin Infect Dis. 2019 Jul 11. pii: 5531519. doi: 10.1093.
    PubMed     Abstract available


    June 2019
  110. LODISE TP, Rosenkranz SL, Finnemeyer M, Evans S, et al
    The Emperor's New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE).
    Clin Infect Dis. 2019 Jun 3. pii: 5510260. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  111. HYLE EP, Scott JA, Sax PE, Millham LRI, et al
    Clinical impact and cost-effectiveness of genotype testing at HIV diagnosis in the United States.
    Clin Infect Dis. 2019 May 4. pii: 5485834. doi: 10.1093.
    PubMed     Abstract available


  112. DONG HV, Pham LQ, Nguyen HT, Nguyen MXB, et al
    Decreased Cephalosporin Susceptibility of Oropharyngeal Neisseria Species in Antibiotic-Using Men-who-have-sex-with-men of Hanoi, Vietnam.
    Clin Infect Dis. 2019 May 3. pii: 5485149. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  113. TORNHEIM JA, Starks AM, Rodwell TC, Gardy JL, et al
    Building the framework for standardized clinical laboratory reporting of next generation sequencing data for resistance-associated mutations in Mycobacterium tuberculosis complex.
    Clin Infect Dis. 2019 Mar 18. pii: 5382557. doi: 10.1093.
    PubMed     Abstract available


  114. MYER L, Redd AD, Mukonda E, Lynch BA, et al
    Antiretroviral adherence, elevated viral load and drug resistant mutations in HIV-infected women initiating treatment in pregnancy: a nested case-control study.
    Clin Infect Dis. 2019 Mar 16. pii: 5381972. doi: 10.1093.
    PubMed     Abstract available


  115. KAYE KS, Rice LB, Dane A, Stus V, et al
    Fosfomycin for injection (ZTI-01) vs Piperacillin-Tazobactam (PIP-TAZ) for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP): ZEUS, A Phase 2/3 Randomized Trial.
    Clin Infect Dis. 2019 Mar 6. pii: 5370034. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  116. BULABULA ANH, Nelson JA, Musafiri EM, Machekano R, et al
    Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
    Clin Infect Dis. 2019 Feb 13. pii: 5316466. doi: 10.1093/cid/ciy1105.
    PubMed     Abstract available


  117. POLSFUSS S, Hofmann-Thiel S, Merker M, Krieger D, et al
    Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment.
    Clin Infect Dis. 2019 Feb 2. pii: 5305974. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  118. HOCQUELOUX L, Raffi F, Prazuck T, Bernard L, et al
    Dolutegravir monotherapy versus dolutegravir/abacavir/lamivudine for virologically suppressed people living with chronic HIV infection: the randomized non-inferiority MONCAY trial.
    Clin Infect Dis. 2019 Jan 2. pii: 5269432. doi: 10.1093/cid/ciy1132.
    PubMed     Abstract available


    December 2018
  119. JOSEPH SB, Kincer LP, Bowman NM, Evans C, et al
    HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
    Clin Infect Dis. 2018 Dec 18. pii: 5252031. doi: 10.1093/cid/ciy1066.
    PubMed     Abstract available


  120. MBISA JL, Kirwan P, Tostevin A, Ledesma J, et al
    Determining the origins of HIV-1 drug-resistant minority variants in people who are recently infected using phylogenetic reconstruction.
    Clin Infect Dis. 2018 Dec 11. pii: 5238064. doi: 10.1093/cid/ciy1048.
    PubMed     Abstract available


    November 2018
  121. DORJEE K, Topgyal S, Dorjee C, Tsundue T, et al
    High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children.
    Clin Infect Dis. 2018 Nov 20. pii: 5193441. doi: 10.1093.
    PubMed     Abstract available


  122. LE HINGRAT Q, Collin G, Le M, Peytavin G, et al
    A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain.
    Clin Infect Dis. 2018 Nov 1. pii: 5153362. doi: 10.1093.
    PubMed     Abstract available


  123. LOWENTHAL P, Lin SG, Desmond E, Shah N, et al
    Evaluation of the impact of a sequencing assay for detection of drug resistance on the clinical management of tuberculosis.
    Clin Infect Dis. 2018 Nov 1. pii: 5154873. doi: 10.1093.
    PubMed     Abstract available


    October 2018
  124. DANINO D, Givon-Lavi N, Ben-Shimol S, Greenberg D, et al
    Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal colonization following pneumococcal conjugate vaccines implementation in young children.
    Clin Infect Dis. 2018 Oct 29. pii: 5146358. doi: 10.1093.
    PubMed     Abstract available


  125. PAPANICOLAOU GA, Silveira FP, Langston AA, Pereira MR, et al
    Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study.
    Clin Infect Dis. 2018 Oct 16. pii: 5133438. doi: 10.1093.
    PubMed     Abstract available


  126. HUANG H, Ding N, Yang T, Li C, et al
    Cross-sectional whole-genome sequencing and epidemiological study of multidrug-resistant Mycobacterium tuberculosis in China.
    Clin Infect Dis. 2018 Oct 15. pii: 5130581. doi: 10.1093.
    PubMed     Abstract available


  127. LESTRADE PP, Bentvelsen RG, Schauwvlieghe AFAD, Schalekamp S, et al
    Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.
    Clin Infect Dis. 2018 Oct 11. pii: 5127014. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  128. BUI DP, Oren E, Roe DJ, Brown HE, et al
    A Case Control Study to Identify Community Venues Associated with Genetically Clustered Multidrug-Resistant Tuberculosis Disease in Lima, Peru.
    Clin Infect Dis. 2018 Sep 5. pii: 5090843. doi: 10.1093.
    PubMed     Abstract available


    August 2018
  129. ZHAO Y, Fox T, Manning K, Stewart A, et al
    Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug resistant tuberculosis: a retrospective cohort study.
    Clin Infect Dis. 2018 Aug 24. pii: 5079132. doi: 10.1093.
    PubMed     Abstract available


  130. CHEMALY RF, Chou S, Einsele H, Griffiths P, et al
    Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials.
    Clin Infect Dis. 2018 Aug 22. pii: 5077870. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: